I agree. They're all bound by NDA's. If they relay info they're not suppose to, they're screwed. It would be detrimental to the company as well, especially in the OTC's. It would be nice to know more, but I'd rather have it be solid info. I'm uncomfortable with the lack of info, but I can understand from a business standpoint and I'll deal with it. When I get solid info, I'll make an informed investment decision.